Multistep targeted nano drug delivery system aiming at leukemic stem cells and minimal residual disease

Molecular Pharmaceutics

Volumn 10, Issue 6, 2013, Pages 2479-2489

  Shi, Yongping ^a   Su, Zhigui ^a   Li, Sai ^a   Chen, Yinan ^a   Chen, Xi ^a   Xiao, Yanyu ^a   Sun, Minjie ^a   Ping, Qineng ^a   Zong, Li ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

leukemic stem cell; minimal residual disease; multistep targeting delivery; refractory leukemia

Indexed keywords

ALENDRONIC ACID; CYCLOPHOSPHAMIDE; FOLIC ACID; HYDROXYAPATITE; MACROGOL; NANOMATERIAL; PHOSPHOLIPID TRANSFER PROTEIN; RETINOIC ACID; STEARIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL UPTAKE; CELLULAR PARAMETERS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; DRUG TRANSPORT; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VIVO STUDY; LEUKEMIA CELL; LEUKEMIA STEM CELL; MINIMAL RESIDUAL DISEASE; MOUSE; NANO DRUG DELIVERY SYSTEM; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SYNTHESIS; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; DURAPATITE; FOLIC ACID; HUMANS; LEUKEMIA; LEUKOCYTES; MICE; MITOXANTRONE; NEOPLASM, RESIDUAL; NEOPLASTIC STEM CELLS; POLYETHYLENE GLYCOLS; RATS;

EID: 84878664206     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp4001266     Document Type: Article

References (37)

1. Campana, D. Progress of minimal residual disease studies in childhood acute leukemia Curr. Hematol. Malig. Rep. 2010, 5 (3) 169-76
2. Laczika, K.; Mitterbauer, G.; Mitterbauer, M.; Knobl, P.; Schwarzinger, I.; Greinix, H. T.; Rabitsch, W.; Fonatsch, C.; Mannhalter, C.; Lechner, K.; Jaeger, U. Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions Leuk. Lymphoma 2001, 42 (5) 923-31
3. Ishikawa, F.; Yoshida, S.; Saito, Y.; Hijikata, A.; Kitamura, H.; Tanaka, S.; Nakamura, R.; Tanaka, T.; Tomiyama, H.; Saito, N.; Fukata, M.; Miyamoto, T.; Lyons, B.; Ohshima, K.; Uchida, N.; Taniguchi, S.; Ohara, O.; Akashi, K.; Harada, M.; Shultz, L. D. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region Nat. Biotechnol. 2007, 25 (11) 1315-21
4. Reya, T.; Morrison, S. J.; Clarke, M. F.; Weissman, I. L. Stem cells, cancer, and cancer stem cells Nature 2001, 414 (6859) 105-11
5. Wang, D.; Miller, S.; Sima, M.; Kopeckova, P.; Kopecek, J. Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems Bioconjugate Chem. 2003, 14 (5) 853-9
6. Moore, N. W.; Kuhl, T. L. The role of flexible tethers in multiple ligand-receptor bond formation between curved surfaces Biophys. J. 2006, 91 (5) 1675-87
7. Ross, J. F.; Wang, H.; Behm, F. G.; Mathew, P.; Wu, M.; Booth, R.; Ratnam, M. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia Cancer 1999, 85 (2) 348-57
8. Pan, X. Q.; Zheng, X.; Shi, G.; Wang, H.; Ratnam, M.; Lee, R. J. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid Blood 2002, 100 (2) 594-602
9. Gao, H.; Qian, J.; Cao, S.; Yang, Z.; Pang, Z.; Pan, S.; Fan, L.; Xi, Z.; Jiang, X.; Zhang, Q. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles Biomaterials 2012, 33 (20) 5115-23
10. Bukowski, J. F.; Dascher, C. C.; Das, H. Alternative bisphosphonate targets and mechanisms of action Biochem. Biophys. Res. Commun. 2005, 328 (3) 746-50
11. Suzuki, N.; Ohneda, O.; Minegishi, N.; Nishikawa, M.; Ohta, T.; Takahashi, S.; Engel, J. D.; Yamamoto, M. Combinatorial Gata2 and Sca1 expression defines hematopoietic stem cells in the bone marrow niche Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (7) 2202-7
12. Williams, D. A.; Cancelas, J. A. Leukaemia: niche retreats for stem cells Nature 2006, 444 (7121) 827-8
13. Zhang, J.; Niu, C.; Ye, L.; Huang, H.; He, X.; Tong, W. G.; Ross, J.; Haug, J.; Johnson, T.; Feng, J. Q.; Harris, S.; Wiedemann, L. M.; Mishina, Y.; Li, L. Identification of the haematopoietic stem cell niche and control of the niche size Nature 2003, 425 (6960) 836-41
14. Yang, D. B.; Zhu, J. B.; Huang, Z. J.; Ren, H. X.; Zheng, Z. J. Synthesis and application of poly(ethylene glycol)-cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles Colloids Surf., B 2008, 63 (2) 192-9
15. Gabizon, A.; Horowitz, A. T.; Goren, D.; Tzemach, D.; Mandelbaum-Shavit, F.; Qazen, M. M.; Zalipsky, S. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies Bioconjugate Chem. 1999, 10 (2) 289-98
16. Sun, M.; Wang, Y.; Shen, J.; Xiao, Y.; Su, Z.; Ping, Q. Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo Nanotechnology 2010, 21 (47) 475101
17. Kuljanin, J.; Jankovic, I.; Nedeljkovic, J.; Prstojevic, D.; Marinkovic, V. Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions J. Pharm. Biomed. Anal. 2002, 28 (6) 1215-20
18. Riviere, K.; Huang, Z.; Jerger, K.; Macaraeg, N.; Szoka, F. C. Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration J. Drug Targeting 2011, 19 (1) 14-24
19. Zhuang, J.; Ping, Q.; Song, Y.; Qi, J.; Cui, Z. Effects of chitosan coating on physical properties and pharmacokinetic behavior of mitoxantrone liposomes Int. J. Nanomed. 2010, 5, 407-16
20. Choi, S. W.; Kim, J. H. Design of surface-modified poly(D,L-lactide-co- glycolide) nanoparticles for targeted drug delivery to bone J. Controlled Release 2007, 122 (1) 24-30
21. Wang, H.; Zheng, X.; Behm, F. G.; Ratnam, M. Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia Blood 2000, 96 (10) 3529-36
22. Frost, H. M.; Villaneuva, A. R.; Roth, H. Measurement of bone formation in a 57 year old man by means of tetracyclines Henry Ford Hosp. Med. Bull. 1960, 8, 239-54
23. Pignatello, R.; Cenni, E.; Micieli, D.; Fotia, C.; Salerno, M.; Granchi, D.; Avnet, S.; Sarpietro, M. G.; Castelli, F.; Baldini, N. A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate Nanomedicine (London) 2009, 4 (2) 161-75
24. Gualbert, J.; Shahgaldian, P.; Coleman, A. W. Interactions of amphiphilic calix[4]arene-based solid lipid nanoparticles with bovine serum albumin Int. J. Pharmaceutics 2003, 257 (1-2) 69-73
25. Shahgaldian, P.; Da Silva, E.; Coleman, A. W.; Rather, B.; Zaworotko, M. J. Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters Int. J. Pharmaceutics 2003, 253 (1-2) 23-38
26. Lim, S. J.; Kim, C. K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid Int. J. Pharmaceutics 2002, 243 (1-2) 135-46
27. Liang, X.; Mao, G.; Ng, K. Y. Effect of chain lengths of PEO-PPO-PEO on small unilamellar liposome morphology and stability: an AFM investigation J. Colloid Interface Sci. 2005, 285 (1) 360-72
28. Valencia, P. M.; Hanewich-Hollatz, M. H.; Gao, W.; Karim, F.; Langer, R.; Karnik, R.; Farokhzad, O. C. Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles Biomaterials 2011, 32 (26) 6226-33
29. Dolman, M. E.; Harmsen, S.; Storm, G.; Hennink, W. E.; Kok, R. J. Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells Adv. Drug Delivery Rev. 2010, 62 (14) 1344-57
30. Lee, R. J.; Low, P. S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis J. Biol. Chem. 1994, 269 (5) 3198-204
31. Zhang, S.; Gangal, G.; Uludag, H. "Magic bullets" for bone diseases: progress in rational design of bone-seeking medicinal agents Chem. Soc. Rev. 2007, 36 (3) 507-31
32. Li, S. D.; Huang, L. Pharmacokinetics and biodistribution of nanoparticles Mol. Pharmaceutics 2008, 5 (4) 496-504
33. Chang, C. W.; Barber, L.; Ouyang, C.; Masin, D.; Bally, M. B.; Madden, T. D. Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 mice Br. J. Cancer 1997, 75 (2) 169-77
34. Shea, J. E.; Miller, S. C. Skeletal function and structure: implications for tissue-targeted therapeutics Adv. Drug Delivery Rev. 2005, 57 (7) 945-57
35. Li, M.; Liang, H.; Shen, Y.; Wronski, T. J. Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats Bone 1999, 24 (2) 95-100
36. Ricci, C.; Cova, M.; Kang, Y. S.; Yang, A.; Rahmouni, A.; Scott, W. W., Jr.; Zerhouni, E. A. Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study Radiology 1990, 177 (1) 83-8
37. Russell, R. G. Bisphosphonates: mode of action and pharmacology Pediatrics 2007, 119 (Suppl 2) S150-62